Bio
Dr Christos Kontogiorgis is Associate Professor of Hygiene at the Medical School, Democritus University of Thrace, Alexandroupolis, Greece. He participates in many undergraduate and postgraduate courses. He has recently co-organized the Postgraduate Course entitled “Primary Health Care”. He has organized the first research group of pharmacoepidemiological studies in Greece and he is the coordinator of the Greek Symposium on Pharmacoepidemiology, which was organized five times. He is co founder of Hellenic Society of Pharmacopeidmeiology. He is representative of Greece in ENCePP and he has been elected as member of ENCePP Steering Group He is a co author or author of correspondence in over 90 PubMed-indexed and Scopus-indexed papers and 250 studies presented in National and International Conferences. He is supervisor of Postdocroral Resarchers and PhD, Master and undergraduate students. He has been involved in many European and national research projects either as PI or as member of the research group.

Bio
Theoklis Zaoutis, MD, PHD is currently Professor of Pediatrics at the School of Medicine of the National Kapodistrian University of Athens He is Emeritus Professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania (PENN)/Division of Infectious Diseases, Children’s Hospital of Philadelphia (CHOP) and Adjunct Professor of Epidemiology at Columbia Universtiy. Dr. Zaoutis is an internationl leader in public health, epidemiology and pediatrics. As a researcher, he was NIH contract funded investigator and in addition to leading l pediatric infectious diseases epidemiology research at Children’s Hospital of Philadelphis (CHOP where he also he directed CHOPs Center for Pediatric Clinical Effectiveness Research Group. Recently, Dr. Zaoutis relocated to Greece to serve on the country’s COVID-19 Task Force. It was in recognition of his work on the task force that he was chosen to lead the Greek CDC in the midst of the pandemic. In his role, we was responsible for setting national COVID-19 vaccine policy and analyzing and presenting data on the vaccine use and effectiveness. He has published over 370 articles including work related to vaccines. Although his research focus has been in the area of antimicrobial resistance and healthcare epidemiology, his methodologic expertise is in pharmacoepidemiology. He as co-PI of our CHOP/PENN NIH Pediatric Pharmacoepidemiology T32 Training Grant and Associate Editor for Pharmacoepidemiology and Drug Safety.. He served on the White House Forum on Antimicrobial Resistance. He has been awarded multiple distinctions, including the Healthcare Epidemiology Pediatric Investigator Award in 2009 and the Distinguished Service Award by the Pediatric Infectious Diseases Society in 2015.

Bio
Dr. Pantelis Natsiavas is a Researcher (Grade C) at the Institute of Applied Biosciences of the Centre for Research and Technology Hellas (INAB|CERTH), where he heads the eHealth Lab. At the same time, he is a Collaborating Researcher of the Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en eSanté - LIMICS (Paris, France). He holds a PhD from the Sorbonne University (Paris, France) and has received two Master's Degrees as well as a Diploma in Electrical Engineering and Computer Engineering from the Aristotle University of Thessaloniki (Thessaloniki, Greece). He has been awarded a scholarship by the French Government while he has also collaborated with companies both in Greece and abroad, providing software development and consulting services for more than 15 years. Since 2013, he has participated in a number of European and national research and development projects in the field of Medical Informatics regarding the use of real-world data, telemedicine systems, data security in the field of health, drug safety and pharmacovigilance etc. His research activities focus on the use of Symbolic Artificial Intelligence and Knowledge Engineering approaches (development and use of ontologies and knowledge graphs). At the same time, he has been responsible on behalf of INAB|CERTH in a number of research projects funded either by industry, or through European and national funding schemes. Indicatively, he has been the Technical Coordinator of the MyPal research project (Horizon 2020 funding framework), which was coordinated by INAB|CERTH and the Principal Investigator and Coordinator for the PVClinical project (Research-Create-Innovate funding framework). He is currently responsible for the national hub of the international OHDSI network for Greece on behalf of INAB|CERTH and for the Registry of Patients with Mechanical Ventilation at Home and Primary Investigator for three (3) research and development projects in the field of eHealth. Finally, he is the (co)supervisor of several theses and PhDs, two in Greece and one in France.

Talk
Cross National Comparisons of Drug Utilization

Bio
Björn Wettermark, M.Sc.Pharm, PhD is professor of pharmacoepidemiology at Uppsala university, Sweden and visiting professor at Vilnius university, Lithuania. His research focus on drug utilization as a tool in health policy including prescribing quality indicators, international comparisons of drug utilization, sustainable drug prescribing, evidence generation for new medicines and patient adherence to treatment. He has previously had various managerial positions in the health region of Stockholm as well as other commitments including membership in national and regional strategic groups on medicine management, scientific advisor to the Swedish Medical Products Agency and chair of the European Drug Utilization Research group (EuroDURG), the European chapter of the International Society for Pharmacoepidemiology

Talk
Federated International Real-World Evidence: The Present and Future of Pharmacoepidemiology

Bio
Professor Daniel Prieto-Alhambra (MD, MSc (Oxon), PhD) is a clinician scientist with over 15 years’ experience in pharmacoepidemiology and real-world evidence. He is Professor of Pharmacoepidemiology at the University of Oxford, leads the Health Data Sciences section at the Botnar Research Centre, and has been Deputy Director of the EMA-funded DARWIN EU® initiative since 2022, also leading the HDR UK Real World Evidence Pilot Network. His research focuses on the analysis of national and international routine health data to inform regulatory and HTA decision-making. He has published over 420 papers (h-index 78) and has extensive experience supervising PhD students and mentoring researchers from assistant to associate professor.

Bio
Dr. Douros is an Associate Professor at the Institute of Clinical Pharmacology and Toxicology at Charité – Universitätsmedizin Berlin. He received his Medical Degree in 2009 and his Doctorate Degree (Dr. med.) in 2012, and was trained in Clinical Pharmacology from 2012 to 2016 at Charité. He then completed a post-doctoral fellowship in Pharmacoepidemiology from 2016 to 2018 at the Department of Epidemiology, Biostatistics and Occupational Health at McGill University. From 2019 to 2023, he worked as an Assistant Professor at the McGill Department of Medicine and as an Investigator at the Lady Davis Institute for Medical Research at the Jewish General Hospital in Montreal. In 2023, he joined the Charité Institute of Clinical Pharmacology and Toxicology as an Associate Professor. Dr. Douros's research focuses on the effectiveness and safety of commonly prescribed medications in vulnerable populations, including patients with chronic liver disease, older adults, and patients subjected to polypharmacy and at risk of drug-drug interactions. Given the underrepresentation of such populations in randomized trials, his research program provides much needed information regarding the benefit-risk profile of drugs. His research is supported by the German Research Foundation (Heisenberg Program 2023-present).

Bio
Farzin Khosrow-Khavar, PhD, is an Assistant Professor of Epidemiology at the Rutgers School of Public Health and a core faculty member of the Center for Pharmacoepidemiology and Treatment Science (PETS) at the Rutgers Institute for Health. His research focuses on cancer pharmacoepidemiology, with an emphasis on the utilization and comparative effectiveness and safety of cancer therapies. His work leverages large linked electronic health records data sources such as SEER-Medicare and Veterans Affairs data to inform clinical and regulatory decision-making.

Bio
Sophie is an Assistant Professor in Pharmacoepidemiology Methods. She has a background in Epidemiology and has experience with using regular care data for research from her PhD on sex differences in the safety and efficacy of cardiovascular medication. Her work focusses on the methodological challenges surrounding the use of real world data for research in the topic areas of safety of COVID-19 vaccinations and sex differences in de safety and dosage of cardiovascular medication